期刊文献+

瘦素、胰岛素及IL-6对平滑肌细胞瘦素受体mRNA表达的影响 被引量:6

EFFECTS OF LEPTIN,INSULIN AND IL-6 ON LEPTIN RECEPTORS mRNA EXPRESSION IN RAT SMC
下载PDF
导出
摘要 目的研究瘦素、胰岛素及IL-6对平滑肌细胞瘦素受体(Ob-R)mRNA表达的影响。方法采用六孔板培养皿培养鼠平滑肌细胞,5个孔作为一个浓度组,通过半定量的RT-PCR方法,分别观察了不同浓度的大鼠瘦素、胰岛素及IL-6对平滑肌细胞瘦素受体mRNA表达水平的影响。结果通过半定量RT-PCR,我们检测了短型瘦素受体(Ob-Ra)和长型瘦素受体(Ob-Rb)的mRNA表达水平,瘦素受体(Ob-R)mRNA表达水平随着瘦素及IL-6浓度增加而上升,随着胰岛素的浓度增加而下降。结论瘦素及IL-6可在体外上调平滑肌细胞瘦素受体的表达,胰岛素可下调平滑肌细胞瘦素受体的表达。这三个因子参与了瘦素受体的表达调控,对我们了解瘦素抵抗的发生机制有重要意义。 Objective To study the effects of leptin, insulin and IL-6 on the mRNA expression of leptin receptor isoforms in rat smooth muscular cells (SMC). Methods Rat smooth muscular cells were cultured in six-well plates and incubated for 24 hours in serum-free media containing leptin, insulin or IL- 6 of different concentrations. The mRNA expression of short-form leptin receptors (Ob-Ra) and long-form leptin receptors (Ob-Rb) was detected by semi-quantitatibe RT-PCR. Results Ob-Ra and Ob-Rb expressed in SMC. Ob-R mRNA expression was increased by Leptin and IL-6, but decreased by Insulin. Conclusion In SMC, Ob-R expression was influenced by leptin, IL-6 and insulin. This is vital for us to study the mechanism of leptin resistance .
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2010年第1期11-14,共4页 Chinese Journal of Histochemistry and Cytochemistry
关键词 瘦素 胰岛素 IL-6 瘦素受体 基因表达 Leptin Insulin IL-6 Leptin receptor Gene expression
  • 相关文献

参考文献16

  • 1Zhang Y,Proenca R,Maffei M,et al.Positional cloning of the mouse Obese gene and its human homologue.Nature,1994,372:425-432.
  • 2Gwo-Hwa Lee,Proenca R,Montez J M.Abnormal splicing of the leptin receptor in diabetic mice.Nature,1996,379(6566):632-635.
  • 3A Michael Wallace,Alex D.McMahon,Chris J.Packard,et al.Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).Circulation,2001,104:3052-3056.
  • 4Jarrod D,Knudson U,Deniz Dincer,et al.Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction.Am J Physiol Heart Circ Physiol,2005,289:48-56.
  • 5Peter F Bodary,Yuechun Shen,Miina O¨ hman,et al.Leptin regulates neointima formation after arterial Injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.Arteriosclerosis,Thrombosis,and Vascular Biology,2007,27:70-76.
  • 6王丽,唐澜,赵勇,黄芬,王华兵,王洪杰,曾和松.瘦素对大鼠主动脉平滑肌细胞迁移和增殖的影响[J].中国动脉硬化杂志,2006,14(11):937-939. 被引量:7
  • 7Sandrine Belouzard,Delphine Delcroix,Yves Rouille,et al.Low levels of expression of leptin receptor at the cell surface result from constitutive endocytosis and intracellular retention in the biosynthetic pathway.Biological Chemistry,2004,279:28499-28508.
  • 8Cassy S,Derouet M,Crochet S.Leptin and insulin downregulate leptin receptor gene expression in chicken-derived leghorn male hepatoma cells.Poultry Science,2003,82:1573-1579.
  • 9Baskin DG,Figlewigz Lattemann DF,Seeley RI,et al.Insulin and leptin:dual adiposity signals to the brain for the regulation of food intake and body weight.Brain Res,1999,848:114-123.
  • 10Pe'rez C,Ferna'ndez-Galaz C,Ferna'ndez-Agullo' T,et al.Leptin impairs insulin signaling in rat adipocytes.Diabetes 2004,53:347-353.

二级参考文献10

  • 1Mario Baratta.Leptin:from a signal of adiposity to a hormonal mediator in peripheral tissues[J].Med Sci Monit,2002,8 (12):RA282-292
  • 2Stephen Gunther,Wayne Alexander R,Atkinson William J,Gimbrone Michael A.Functional angiotensinII receptors in cultured vascular smooth muscle cells[J].The Journal of Cell Biology,1982,92:289-298
  • 3Stephan Goetze,Anne Bungenstock,Cornelia Czupalla,Friedrich Eilers,Philipp Stawowy,Ulrich Kintscher,et al.Leptin induces endothelial cell migration through Akt,which is inhibited by PPARγ-ligands[J].Hypertension,2002,40:748-754
  • 4Katrin Schafer,Martin Halle,Colin Goeschen,Claudia Dellas,Marianne Pynn,David J.Leptin promotes vascular remodeling and neointimal growth in mice[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2004,24 (1):112-117
  • 5Bodary PF,Westrick RJ,Wickenheiser KJ,Shen Y,Eitzman DT.Effect of leptin on arterial thrombosis following vascular injury in mice[J].JAMA,2002,287:1 706-709
  • 6Beltowski J,Wojcicka G,Jamroz A.Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress:the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia[J].Atherosclerosis,2003,170 (1):21-29
  • 7Wallace Am,Mc Mahon AD,Packard CJ.Plasma leptin and the risk of cardiovascular disease in the west of scotland coronary prevention study (WOSCOPS)[J].Circulation,2001,104 (25):3 052-056
  • 8Christian Bjorbak,Shigeo Uotani,Barbara da Silva,Flier Jeffrey S.Divergent signaling capacities of the long and short isoforms of the leptin receptor[J].J Biol Chem,1997,272:32 686-695
  • 9Nico Ghilardi,Radek C,Skoda.The leptin receptor activates janus kinase2 and signals for proliferation in a factor-dependent cell line[J].Molecular Endocrinology,1997,11 (4):393-399
  • 10韩英,谢良地.血管平滑肌细胞迁移的调控机制[J].高血压杂志,2003,11(2):98-101. 被引量:7

共引文献6

同被引文献78

  • 1Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus [ J ]. Ann Surg, 1995,222 ( 3 ) : 339-350 ; discussion 350-352.
  • 2PoweU MS,Fernandez AZ Jr. Surgical treatment for morbid obesity: the laparoscopic Roux-en-Y gastric bypass[J]. Surg Clin North Am, 2011,91(6) :1203-1224.
  • 3Pender C, Goldfine ID, Tanner C J, et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia[ J]. Int J Obes Relat Metab Disord ,2004,28 (3) :363-369.
  • 4Sarr MG. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic eholecysteetomy nor treatment with ursodeoxycholic acid is necessary after open RYGB [ J ]. Surg Obes Relat Dis, 2006,2 (2) :233 ; author reply 233.
  • 5李震.Roux-en-Y胃转流手术治疗2型糖尿病的临床疗效观察[c][硕士].重庆医科大学,2012.
  • 6Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus[ J]. Ann Surg, 21303,238 (4) :467-484 ;discussion 484-485.
  • 7Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution [ J]. J Clin Endocrinol Metab,2004,89 (6) :2608-2615.
  • 8Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes [ J ]. Diabetes Care,2003,26 (10) :2929-2940.
  • 9Scopinaro N, Papadia F, Marinari G, et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2[J]. Obes Surg,2007,17(2) :185-192.
  • 10Dixon JB, OBrien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial [ J ]. JAMA, 2008,299 ( 3 ) : 3 16 -323.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部